Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Plamotamab by Xencor for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Plamotamab is under clinical development by Xencor and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to GlobalData,...
Data Insights
Plamotamab by Xencor for Non-Hodgkin Lymphoma: Likelihood of Approval
Plamotamab is under clinical development by Xencor and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData, Phase I...